MASTER IN BIOINFORMATICS, IN SILICO DRUG DESIGN MODELING OF MACROMOLECULES
Language(s) of instruction: Year 1: English-French (20%-80%)
Year 2: English-French (80%-20%)
Length of study: 2 years, full time
Partner: Università degli Studi di Milano: an exchange semester may be undertaken during the second semester of the first year (Master 1)
Course Location:
- Semester 1: Université Paris Cité, Paris, France
- Semester 2: Université Paris Cité, Paris, France (or Università degli Studi di Milano, Milan, Italy, in case of undertaking an exchange semester)
- Semester 3: Université Paris Cité, Paris, France
- Semester 4: Location depending on the internship
Degrees awarded: Master Mention Bio-Informatique, Parcours : In Silico Drug Design – Modeling of Macromolecules, Université Paris Cité
Entry Requirements: Bachelor degree or international equivalent in a variety of subjects including chemistry, biochemistry, bioinformatics, biology, biotechnology, or the health sector
Language pre-requisites: B2 level of French and English
Course overview
The Master’s programme in In Silico Drug Design (ISDD) – Modeling of macromolecules, included in the Master’s degree of Bioinformatics (UFR of Life Sciences), was created in response to growing demand from both the pharmaceutical industry and academia to train students in this rapidly expanding field in France and Europe. Interdisciplinary in nature, the ISDD Master’s programme benefits from the collaboration of several universities, private companies, and international experts.
Oriented towards the modelling and design of macromolecules, with a focus on molecular docking, molecular dynamics, artificial intelligence, and deep learning, the programme aims to provide comprehensive training in all aspects of drug discovery using in silico (computer-assisted) approaches.
More information is provided on the website: https://isddteach.rpbs.univ-paris-diderot.fr/fr/accueil.html
Skills and competencies developed
In silico research training in the modeling of macromolecules, with preparation for further doctoral studies.
Skills development in rational exploration of macromolecular targets, by combining artificial intelligence, deep learning, molecular docking, molecular dynamics and virtual screening approaches.
Career readiness, enabling graduates to participate in or lead in silico drug design projects within pharmaceutical and medicinal chemistry companies, as well as in organizations developing specialized software.
Contact
Pedagogical Coordinators
Pr. Anne-Claude Camproux
anne-claude.camproux@u-paris.fr
Administrative Coordinator
Ms. Aïssétou Traoré
aissetou.traore@u-paris.fr